Have a feature idea you'd love to see implemented?
Let us know!
GNPX Genprex Inc
Price (delayed)
$0.8878
Market cap
$7.55M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$11.68
Enterprise value
$6.07M
Genprex, Inc. is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Genprex's technologies are designed to administer disease-fighting genes to provide new
Highlights
The company's EPS has surged by 52% YoY and by 26% QoQ
The net income has grown by 28% year-on-year and by 13% since the previous quarter
Genprex's equity has plunged by 86% YoY and by 62% from the previous quarter
GNPX's quick ratio has dropped by 76% year-on-year and by 39% since the previous quarter
Key stats
What are the main financial stats of GNPX
Market
Valuations
Earnings
Shares outstanding
8.51M
Market cap
$7.55M
Enterprise value
$6.07M
Price to earnings (P/E)
N/A
Price to book (P/B)
1.38
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
Gross profit
$0
Net income
-$22.71M
EBIT
-$22.71M
EBITDA
-$22.7M
Free cash flow
-$18.24M
Per share
Balance sheet
Liquidity
EPS
-$11.68
EPS diluted
-$11.68
Free cash flow per share
-$5.21
Book value per share
$0.64
Revenue per share
$0
TBVPS
$1.12
Total assets
$3.91M
Total liabilities
$2.24M
Debt
$0
Equity
$1.66M
Working capital
-$324,791
Debt to equity
0
Current ratio
0.86
Quick ratio
0.66
Net debt/EBITDA
0.07
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-269.2%
Return on equity
-409.5%
Return on invested capital
-5,288.8%
Return on capital employed
-1,364%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
GNPX stock price
How has the Genprex stock price performed over time
Intraday
-4.35%
1 week
-1.36%
1 month
-20.73%
1 year
-89.51%
YTD
-90.35%
QTD
145.45%
Financial performance
How have Genprex's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$22.83M
Net income
-$22.71M
Gross margin
N/A
Net margin
N/A
The net income has grown by 28% year-on-year and by 13% since the previous quarter
The company's operating income rose by 28% YoY and by 13% QoQ
Growth
What is Genprex's growth rate over time
Valuation
What is Genprex stock price valuation
P/E
N/A
P/B
1.38
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The company's EPS has surged by 52% YoY and by 26% QoQ
Genprex's equity has plunged by 86% YoY and by 62% from the previous quarter
The P/B is 47% below the 5-year quarterly average of 2.7 but 44% above the last 4 quarters average of 1.0
Efficiency
How efficient is Genprex business performance
The ROE has shrunk by 112% YoY and by 29% QoQ
GNPX's ROA has plunged by 73% YoY and by 20% from the previous quarter
The company's return on invested capital rose by 38% YoY and by 31% QoQ
Dividends
What is GNPX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for GNPX.
Financial health
How did Genprex financials performed over time
Genprex's total assets is 74% higher than its total liabilities
Genprex's total assets has shrunk by 77% YoY and by 41% QoQ
GNPX's quick ratio has dropped by 76% year-on-year and by 39% since the previous quarter
Genprex's debt is 100% lower than its equity
Genprex's equity has plunged by 86% YoY and by 62% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.